The consensus was published in the British Journal of Sports...
Category:
Health
Latest
GIS, remote sensing key to battling vector-borne diseases during monsoon: experts
In Bengaluru, where dengue cases exceeded 4,000, a disease...
Exposure to air pollution linked to increased stroke risk within 5 days: Study
``Earlier,the correlation between short-term exposure to air...
Peak will come, virus can again emerge: Govt
NITI Aayog member (health) Dr V K Paul said it is the nature of the disease that it will ultimately go to villages.
This epidemiology is well known, Paul said as he urged people to follow COVID appropriate behaviour and embrace vaccination.
So peak will come, the virus can again emerge, we know. So preparations have to be made at country level in collaboration with states, infrastructure has to be ramped up, containment measures have to be implemented and COVID appropriate behaviour has to be followed, he said.
216 cr vaccine doses to be available in 5 months between Aug-Dec, enough to cover all: Centre
Further, Biological E is expected to produce 30 crore doses, Zydus Cadila 5 crore, Serum Institute of India 20 crore doses of Novavax, and Bharat Biotech 10 crore doses of its nasal vaccine, while Gennova will make available 6 crore doses and Sputnik V 15.6 crore doses, he said. The vaccine candidates of Biological E, Zydus Cadila, Gennova, Bharat Biotech’s nasal vaccine are in various stages of clinical trials.
Mixing AstraZeneca and Pfizer shots triggers more fatigue, headaches: Study
Researchers and public health officials are examining strategies such as blending two different shots as many low- and middle-income nations try to figure out how to cope with vaccine scarcity. Assurance that mismatched shots are still safe and effective would make it easier for governments to manage their stockpiles and provide more insight into a combination that’s already used in some countries.
Pandemic could have been prevented: Expert panel on WHO’s handling of Covid
The WHO should have declared the new coronavirus outbreak in China an international emergency earlier than Jan. 30, 2020, but the next month was “lost” as countries failed to take strong measures to halt spread of the respiratory pathogen, it said.
Arthur J. Gallagher & Co to acquire Willis Re and WTW’s corporate risk, broking, health and benefits services for $3.57 billion
Gallagher has agreed to purchase a group of businesses from Willis Towers Watson that includes:
Willis Re operations globally, excluding operations in mainland China and Hong Kong;
Global cedent facultative reinsurance, excluding operations in mainland China and Hong Kong;
Corporate Risk and Broking business unit known as Inspace globally and certain business undertaken for Aerospace Manufacturing clients;
Religious and political events among factors that accelerated COVID-19 transmission in India:WHO
”While India continues to account for 95% of cases and 93% of deaths in the South-East Asia Region, as well as 50% of global cases and 30% of global deaths, worrying trends have been observed in neighbouring countries,” it said.
Centre allows employees with medical qualification to undertake practice, teleconsultation
“In view of the unprecedented rise in the numbers of COVID-19 cases, and to utilise the in-house capabilities available in the government to contain the spread of COVID-19 virus and to provide relief to the public, it has been decided that the central government employees holding recognised qualifications in any system of medicine requires no permission from the Head of Departments (HoDs) concerned to undertake practice/provide teleconsultation,” it said.
India records 362,727 new coronavirus cases and 4,120 deaths
The active cases have increased to 37,10,525 comprising 15.65 per cent of the total infections.
The national COVID-19 recovery rate has improved to 83.26 per cent, the data updated at 8 am showed.
Delhi, Haryana and Uttar Pradesh are among 10 states that account for 72.42 per cent of the 3,62,727 new cases in the country in a span of 24 hours, the Union Health Ministry said on Thursday.
Kerala, Karnataka, Tamil Nadu, Andhra Pradesh, West Bengal and Rajasthan are the other states in the list of 10.
Maharashtra reported the highest daily new cases at 46,781. It is followed by Kerala with 43,529 while Karnataka reported 39,998 new cases.
World accepts much-maligned China’s Covid-19 vaccine but doubts remain
By January, Sinovac’s vaccine had seen four different efficacy rates — ranging from as high as 91% to as low as 50% — triggering concern among scientists and putting a question mark over its ability to protect against the virus still paralyzing the globe.
Sinovac has already shipped some 380 million doses, more than AstraZeneca Plc and second only to Pfizer Inc. worldwide. But unlike those companies — and even Russia’s Sputnik shot — it still hasn’t published any data in an academic journal, the gold standard experts use to assess a vaccine.
India’s prized investment grade status hanging by a thread
“We still see India as investment grade,” said NN Investment Partners’ head of Asian Debt, Joep Huntjens, who thinks the country’s economy will bounce back quickly. “But we do think there is at least a 50/50 chance that at least one rating agency downgrades, probably next year”.